https://hoeford.com/ 2024-05-22T11:22:47+01:00 weekly 0.5 https://hoeford.com/about-us 2024-04-10T15:54:52+01:00 weekly 0.5 https://hoeford.com/search-results 2022-07-10T21:57:10+01:00 weekly 0.5 https://hoeford.com/resources-2/blog 2024-03-31T14:16:21+01:00 weekly 0.5 https://hoeford.com/contact 2024-03-15T07:14:05+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/our-blog-post-one 2022-08-12T17:52:41+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/our-blog-post-three 2023-01-03T13:00:42+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/our-blog-post-four 2023-05-26T12:26:23+01:00 weekly 0.5 https://hoeford.com/about/animal-welfare-1 2024-03-11T15:40:38+00:00 weekly 0.5 https://hoeford.com/about/quality-assurance 2024-03-11T15:40:17+00:00 weekly 0.5 https://hoeford.com/website-usage-terms-and-conditions 2022-08-10T14:13:42+01:00 weekly 0.5 https://hoeford.com/privacy-policy 2022-08-12T15:33:00+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/vendor-or-partner 2023-10-18T13:38:51+01:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/bookkeeper 2023-01-25T12:47:11+00:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/quality-assurance-manager 2023-01-25T12:46:26+00:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/project-licence-holder 2023-01-25T12:42:37+00:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford 2023-10-13T09:52:05+01:00 weekly 0.5 https://hoeford.com/sandpit 2024-03-31T18:26:54+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/toxicology-gap-between-research-and-regulation 2023-07-24T15:25:42+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/gmp-glp-or-gcp-whats-difference-and-which-one-do-i-need 2023-07-24T17:06:02+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/hoeford-heads-hong-kong 2022-11-15T23:18:55+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/shellie-davies-joins-hoeford-research 2023-01-04T12:21:32+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/gmp-glp-or-gcp-whats-difference-which-one-do-i-need-part-2-glp 2023-07-24T17:06:46+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/avian-flu-vaccination 2023-12-18T13:33:02+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/gmp-glp-or-gcp-whats-difference-which-one-do-i-need-part-3-gcp 2023-07-24T17:08:23+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/bird-flu-pandemic-radar-vaccine-manufacturers-and-governments 2024-01-05T14:10:22+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/made-india-generics-whats-regulatory-risk 2023-07-24T17:10:33+01:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/quality-assurance-officer 2023-05-27T15:49:51+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/why-do-we-need-animal-testing 2023-10-18T13:38:10+01:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/personal-licence-holder 2023-10-13T09:51:52+01:00 weekly 0.5 https://hoeford.com/Careers-at-Hoeford/animal-care-technician 2023-11-12T11:58:32+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/crucial-role-toxicology-research-laboratories-drug-discovery 2024-05-17T13:56:39+01:00 weekly 0.5 https://hoeford.com/resources-2/blog/toxicology-getting-know-subdisciplines 2023-12-18T14:00:30+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/choosing-your-proof-concept-vivo-toxicology-laboratory 2023-11-21T10:10:14+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/paracelsian-principle 2024-01-25T11:52:12+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/hoeford-scales-new-heights 2024-03-27T17:16:21+00:00 weekly 0.5 https://hoeford.com/about/working-medicilon 2024-05-22T11:22:19+01:00 weekly 0.5 https://hoeford.com/solutions 2024-03-26T20:25:56+00:00 weekly 0.5 https://hoeford.com/solutions/preclinical 2024-05-17T14:03:42+01:00 weekly 0.5 https://hoeford.com/solutions/custom-testing 2024-05-22T11:34:40+01:00 weekly 0.5 https://hoeford.com/about 2024-03-26T20:03:39+00:00 weekly 0.5 https://hoeford.com/resources-2 2024-03-31T14:03:30+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2 2024-04-01T12:28:50+01:00 weekly 0.5 https://hoeford.com/solutions/preclinical/lead-optimisation 2024-05-22T11:23:24+01:00 weekly 0.5 https://hoeford.com/solutions/preclinical/safety-and-efficacy 2024-05-22T11:24:01+01:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/bioanalysis-support 2024-03-27T13:32:46+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme 2024-03-28T10:31:51+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme/metabolic-stability-services 2024-03-28T08:52:25+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme/drug-drug-interaction-services 2024-03-28T08:53:51+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme/permeability-and-transporter-services 2024-03-28T08:55:27+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme/available-reaction-phenotyping-services 2024-03-28T08:56:47+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/adme/protein-binding-services 2024-03-28T08:58:54+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/dmpk 2024-03-27T13:34:03+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/toxicology 2024-03-27T13:34:49+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/histopathology 2024-03-27T13:36:16+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/clinical-pathology 2024-03-27T13:36:54+00:00 weekly 0.5 https://hoeford.com/solutions/custom-testing/dose-range-finding 2024-03-27T13:37:43+00:00 weekly 0.5 https://hoeford.com/solutions/services 2024-05-22T11:24:31+01:00 weekly 0.5 https://hoeford.com/solutions/services/toxin-and-antitoxin-testing 2024-03-27T12:34:42+00:00 weekly 0.5 https://hoeford.com/solutions/services/behavioural-toxicology-testing 2024-03-27T12:35:50+00:00 weekly 0.5 https://hoeford.com/solutions/services/dose-range-finding 2024-03-27T12:35:14+00:00 weekly 0.5 https://hoeford.com/solutions/services/antibody-raising 2024-03-27T12:36:33+00:00 weekly 0.5 https://hoeford.com/solutions/services/safety-and-quality-control 2024-03-27T12:37:01+00:00 weekly 0.5 https://hoeford.com/solutions/services/biocide-potency-and-efficacy 2024-03-27T12:37:33+00:00 weekly 0.5 https://hoeford.com/resources-2/blog/cross-border-collaboration-outsourced-research-and-development 2024-03-27T17:18:26+00:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/file-1 2024-04-01T12:29:07+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/file-2 2024-04-01T12:29:32+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/file-3 2024-03-31T11:44:13+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/adc-r-and-d-service-platform 2024-03-31T11:49:27+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/cmc-sector-api-process-development-services 2024-03-31T11:52:43+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/cmc-sector-insoluble-innovation-drug-technology-platform 2024-03-31T11:54:02+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/chemistry-research-services 2024-03-31T11:55:52+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/protac-platform-and-its-application-drug-discovery 2024-03-31T11:58:53+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/preclinical-efficacy-evaluation-service-platform-cerebrovascular-disease 2024-03-31T12:04:31+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/cell-and-gene-therapy-drug-r-and-d-service-platform 2024-03-31T12:06:04+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/glp-1-new-drug-r-and-d-service 2024-03-31T12:09:22+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/single-b-cell-antibody-discovery-platform 2024-03-31T12:13:17+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/nanostring-ncounter-detection-platform 2024-03-31T12:20:48+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/toxicology-studies-services 2024-03-31T12:25:41+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/antibody-r-and-d-service-platform 2024-03-31T12:30:31+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/kras-targeted-drugs-r-and-d-service 2024-03-31T12:34:26+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/stat3-targeted-drugs-r-and-d-service 2024-03-31T12:37:57+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/protac-r-and-d-service-platform 2024-03-31T12:42:40+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/efficacy-studies-and-pkpd-protac-drugs-vitro-and-vivo 2024-03-31T12:46:03+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/efficacy-adc-drugs-vitro-and-vivo 2024-03-31T12:47:54+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/dmpk-poster 2024-03-31T12:50:01+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/drug-routes-administration-platform 2024-03-31T12:52:42+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/ophthalmic-animal-model-dry-eye 2024-03-31T12:58:14+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/high-quality-integrated-drug-r-and-d-services 2024-03-31T13:00:33+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/drug-resistant-tumour-models 2024-03-31T13:04:07+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/synethesis-biology-enzyme-catalytic-platform 2024-03-31T13:07:43+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/dmpk-and-bioanalysis-services 2024-03-31T13:12:10+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/preclinical-nociceptive-pain-models 2024-03-31T13:14:03+01:00 weekly 0.5 https://hoeford.com/resources-2/resources-2-2/peptide-drug-discovery-service-platform 2024-03-31T13:15:14+01:00 weekly 0.5